[{"address1": "IDA Business Park", "city": "Bray", "zip": "A98 H5C8", "country": "Ireland", "phone": "353 1 276 9800", "fax": "353 1 276 9888", "website": "https://www.trinitybiotech.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.", "fullTimeEmployees": 380, "companyOfficers": [{"maxAge": 1, "name": "Mr. John  Gillard", "age": 43, "title": "President, CEO, Company Secretary & Director", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 710000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ronan  O'Caoimh A.C.A.", "age": 68, "title": "Founder, Director & Executive Advisor", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 80000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Walsh Ph.D.", "age": 66, "title": "Executive Director of Business Development & Executive Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  O'Connor", "title": "Interim Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacqueline  O'Neill", "age": 51, "title": "Director of Operations", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Tallon", "title": "Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Keating Ph.D.", "age": 51, "title": "Chief Technology Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eibhlin  Kelly", "age": 40, "title": "Chief Information Officer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Colm  Molloy", "age": 53, "title": "Group Director of Human Resources & Culture", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adrian  Donohue", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.trinitybiotech.com/InvestorRelations/Pages/Company%20Overview.aspx", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6401, "open": 0.64, "dayLow": 0.63, "dayHigh": 0.71, "regularMarketPreviousClose": 0.6401, "regularMarketOpen": 0.64, "regularMarketDayLow": 0.63, "regularMarketDayHigh": 0.71, "exDividendDate": 1433462400, "payoutRatio": 0.0, "fiveYearAvgDividendYield": 1.19, "beta": 1.217, "forwardPE": -0.68737864, "volume": 90858, "regularMarketVolume": 90858, "averageVolume": 2049503, "averageVolume10days": 39910, "averageDailyVolume10Day": 39910, "bid": 0.49, "ask": 0.819, "bidSize": 2, "askSize": 2, "marketCap": 13589423, "fiftyTwoWeekLow": 0.48, "fiftyTwoWeekHigh": 3.55, "priceToSalesTrailing12Months": 0.22983836, "fiftyDayAverage": 0.6612, "twoHundredDayAverage": 1.37235, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 237956320, "profitMargins": -0.34390998, "floatShares": 179775755, "sharesOutstanding": 19194100, "sharesShort": 131028, "sharesShortPriorMonth": 159281, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0068, "heldPercentInsiders": 0.123959996, "heldPercentInstitutions": 0.14628, "shortRatio": 2.74, "shortPercentOfFloat": 0.0095999995, "impliedSharesOutstanding": 7641510, "bookValue": -2.536, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -20331000, "trailingEps": -2.25, "forwardEps": -1.03, "lastSplitFactor": "1:5", "lastSplitDate": 1708646400, "enterpriseToRevenue": 4.025, "enterpriseToEbitda": -27.513, "52WeekChange": -0.6011236, "SandP52WeekChange": 0.07995045, "lastDividendValue": 1.1, "lastDividendDate": 1433462400, "quoteType": "EQUITY", "currentPrice": 0.708, "recommendationKey": "none", "totalCash": 2840000, "totalCashPerShare": 0.014, "ebitda": -8649000, "totalDebt": 93715000, "quickRatio": 0.865, "currentRatio": 1.643, "totalRevenue": 59126000, "revenuePerShare": 6.497, "returnOnAssets": -0.08189, "grossProfits": 21131000, "freeCashflow": -8385625, "operatingCashflow": -7300000, "revenueGrowth": 0.032, "grossMargins": 0.35739, "ebitdaMargins": -0.14628, "operatingMargins": -0.14645, "financialCurrency": "USD", "symbol": "TRIB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 10.6077175, "regularMarketPrice": 0.708, "shortName": "Trinity Biotech plc", "marketState": "CLOSED", "messageBoardId": "finmb_397947", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1745624352, "regularMarketTime": 1745611200, "exchange": "NMS", "postMarketChangePercent": 1.68079, "postMarketPrice": 0.7199, "postMarketChange": 0.0119, "regularMarketChange": 0.0679, "regularMarketDayRange": "0.63 - 0.71", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2049503, "fiftyTwoWeekLowChange": 0.22800002, "fiftyTwoWeekLowChangePercent": 0.47500005, "fiftyTwoWeekRange": "0.48 - 3.55", "fiftyTwoWeekHighChange": -2.842, "fiftyTwoWeekHighChangePercent": -0.8005634, "fiftyTwoWeekChangePercent": -60.11236, "dividendDate": 1435708800, "earningsTimestampStart": 1745931624, "earningsTimestampEnd": 1746622824, "earningsCallTimestampStart": 1731682800, "earningsCallTimestampEnd": 1731682800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.25, "epsForward": -1.03, "epsCurrentYear": -1.74, "priceEpsCurrentYear": -0.40689656, "fiftyDayAverageChange": 0.046800017, "fiftyDayAverageChangePercent": 0.070780426, "twoHundredDayAverageChange": -0.66435, "twoHundredDayAverageChangePercent": -0.48409662, "priceToBook": -0.2791798, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "longName": "Trinity Biotech plc", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 719674200000, "displayName": "Trinity Biotech", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]